Springer Nature OAopen access
SGLT2 inhibitor use and disparities in all-cause mortality in type 2 diabetes: insights from a multi-ethnic population
Medicine & Public Health, Internal Medicine, Metabolic Diseases, Human Physiology
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 319401
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.